Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine-N-Butylbromide vs Ondansetron for PONV and Pain in Laparoscopic Cholecystectomy
NCT06927817Phase 4Completed
- Sponsor
- Sağlık Bilimleri Üniversitesi
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hyoscine butylbromide in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Sağlık Bilimleri Üniversitesi. Primary endpoints: Postoperative Nausea and Vomiting at 24 hours and Postoperative Pain Intensity at 24 hours. Started Nov 2020; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on NCT06927817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06927817.